Effect of dutasteride versus placebo on the treatment of patients with Lichen Planopilaris

Effect of oral dutasteride versus placebo combined with topical clobetasol and minoxidil on the treatment of patients with Lichen Planopilaris: a double-blind randomized clinical trial

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120215009014N568

Enrollment

122

Registered

2025-08-12

Start date

2025-09-23

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen Planopilaris. Lichen planopilaris

Interventions

Intervention 1: Intervention group: Topical treatment with clobetasol lotion (Made by Abu Raihan Pharmaceutical Company) once a night and minoxidil lotion (Made by Nano Pharmed Pharmaceutical Company)

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Age 18 to 70 years Lichen planopilaris

Exclusion criteria

Exclusion criteria: Pregnancy or breastfeeding Any local or systemic treatment within the last 3 months

Design outcomes

Primary

Measure	Time frame
Clinical symptoms of Lichen Planopilaris. Timepoint: Before intervention and 4 months after starting intervention. Method of measurement: Using the Lichen Planopilaris Activity Index.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Fatemeh Judy

Hamedan University of Medical Sciences

fatemehjudy75@gmail.com+98 81 3838 0572

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026